Subscribe to RSS
DOI: 10.1055/s-2006-948177
Efficient Synthesis of Sugar Iminopyrrolidine Derivatives via an Intramolecular Staudinger-aza-Wittig-Type Reaction
Publication History
Publication Date:
24 July 2006 (online)
![](https://www.thieme-connect.de/media/synlett/200612/lookinside/thumbnails/10.1055-s-2006-948177-1.jpg)
Abstract
We report herein the first example of a Staudinger-aza-Wittig-type reaction on a substituted furanoside in which a β-azido glyco-α-aminonitrile was converted into fused iminopyrrolidines in good yields, and the following hydrolysis gave the corresponding conformationally restricted glycoamino acids.
Key words
aza-sugars - Wittig reactions - glycoamino nitrile - glycoamino acids - iNOS
- 1
Moncada S.Higgs EA. FASEB J. 1995, 9: 1319 - 2
Knowles RG.Moncada S. Biochem. J. 1994, 298: 249 - 3
Kawanaka Y.Kobayashi K.Kusuda S.Tatsumi T.Murot M.Nishiyama T.Hisaichi K.Fujii A.Hirai K.Nak M.Komeno M.Odagaki Y.Nakai H.Toda M. Bioorg. Med. Chem. Lett. 2003, 13: 1723 ; and references cited therein -
4a
Ueda S.Terauchi H.Yano A.Iro M.Matsumoto M.Kawasaki M. Bioorg. Med. Chem. Lett. 2004, 14: 313 -
4b
Atkinson RN.Moore L.Tobin J.King SB. J. Org. Chem. 1999, 64: 3467 - 5
Moore WM.Webber RK.Fok KF.Jerome GM.Connor JR.Manning PT.Wyatt PS.Misko TP.Tjoeng FS.Currie MG. J. Med. Chem. 1996, 39: 669 -
6a
Hagen TJ.Bergmanis AA.Kramer SW.Fok KF.Schmelzer AE.Pitzele BS.Swenton L.Jerome GM.Kornmeier CM.Moore WM.Branson LF.Connor JR.Manning PT.Currie MG.Hallinan EA. J. Med. Chem. 1998, 41: 3675 -
6b
Tsymbalov S.Hagen TJ.Moore WM.Jerome GM.Connor JR.Manning PT.Pitzele BS.Hallinan EA. Bioorg. Med. Chem. Lett. 2002, 12: 3337 -
6c
Guthikonda NR.Shah SK.Pacholok SG.Humes JL.Mumford RA.Grant SK.Chabin RM.Green BG.Tsou N.Ball R.Fletcher DS.Luell S.MacIntyre DE.MacCoss M. Bioorg. Med. Chem. Lett. 2005, 15: 1997 - 7
Burden PM. Synth. Commun. 1993, 23: 1195 -
8a
Shankaran K.Donnelly K.Shah SK.Guthikonda RN.MacCoss M.Humes JL.Pacholok SG.Grant SK.Kelly TM.Wong KK. Bioorg. Med. Chem. Lett. 2004, 14: 4539 -
8b
Shankaran K.Donnelly KL.Shah SK.Caldwell CG.Chen P.Hagmann WK.MacCoss M.Humes JL.Pacholok SG.Kelly TM.Grant SK.Wong KK. Bioorg. Med. Chem. Lett. 2004, 14: 5907 -
8c
Gadreau C.Foucaud A. Tetrahedron Lett. 1974, 48: 4243 - 9
Benati L.Bencivenni G.Leardini R.Minozzi M.Nanni D.Scialpi R.Spagnolo P.Zanardi G.Rizzoli C. Org. Lett. 2004, 6: 417 -
10a
Postel D.Nguyen Van Nhien A.Pillon M.Villa P.Ronco G. Tetrahedron Lett. 2000, 41: 6403 -
10b
Nguyen Van Nhien A.Ducatel H.Len C.Postel D. Tetrahedron Lett. 2002, 43: 3805 -
10c
Postel D.Nguyen Van Nhien A.Marco JL. Eur. J. Org. Chem. 2003, 19: 3713 -
10d
Dominguez L.Nguyen Van Nhien A.Tomassi C.Len C.Postel D.Marco-Contelles JL. J. Org. Chem. 2004, 69: 843 -
10e
Nguyen Van Nhien A.Tomassi C.Len C.Marco-Contelles JL.Balzarini J.Pannecouque C.De Clercq E.Postel D. J. Med. Chem. 2005, 48: 4276 - 11
Ewing DF.Goethals G.MacKenzie G.Martin P.Ronco G.Vanbaelinghem L.Villa P. Carbohydr. Res. 1999, 321: 190
References and Notes
(1
R
,3
R
,4
R
,5
R
)-5,6-Diamino-3,4-
O
-isopropylidene-7-aza-2-oxabicyclo[3.3.0]oct-6-ene (
8).
To a solution of compound 2 (0.20 g, 0.85 mmol) in 10 mL of THF-H2O (4:1) was added 0.25 g (0.93 mmol) of PPh3. After stirring overnight at r.t., the reaction mixture was evaporated and extracted with Et2O and H2O. The aqueous layer was evaporated to give 0.16 g (89%) of 8 as a slight yellow syrup; [α]D
20 20 (c 0.17, CHCl3). IR (ATR): 2988, 1655, 1374, 1217, 1165, 1086, 1007, 877, 733 cm-1. 1H NMR (CDCl3): δ = 5.80 (d, 1 H, H-1, J
1,2 = 3.9 Hz), 4.60 (d, 1 H, H-2), 4.30 (d, 1 H, H-4, J
4,5a = 3.0 Hz), 3.72 (dd, 1 H, H-5a, J
5a,5b = 14.0 Hz), 3.67 (d, 1 H, H-5b), 1.53 (s, 3 H, CH3), 1.35 (s, 3 H, CH3). 13C NMR (CDCl3): δ = 168.2 (C=N), 112.9 (CH3
CCH3), 106.1 (C-1), 85.1 (C-4), 82.2 (C-2), 74.1 (C-3), 55.5 (C-5), 27.6, 27.3 (2 × CH3). HRMS: m/z calcd for C9H16N3O3 [M + H]+: 214.1192; found: 214.1196. Anal. Calcd for C9H15N3O3: C, 50.69; H, 7.09; N, 19.71. Found: C, 50.54; H, 6.95; N, 19.60.
Key Data for Compound 9. 13C NMR (CDCl3): δ = 173.4 (C=N, J 2 C-P = 9.0 Hz), 75.4 (C-3, J 3 C-P = 17.2 Hz), 14.4 [P(CH3)3, J 1 CH3-P = 66.0 Hz). MS: m/z = 288.14 [M + H]+.
14
3-Amino-3-deoxy-1,2-
O
-isopropylidene-α-
d-ribofurano-sidurono-3,5-lactam (
17).
White solid, mp 159-162 °C; [α]D
20 18 (c 0.11, CHCl3). 1H NMR (CD3OD): δ = 5.81 (d, 1 H, H-1, J
1,2 = 3.9 Hz), 4.60 (d, 1 H, H-2), 4.40 (d, 1 H, H-4, J
4,5a = 3.5 Hz), 3.65 (dd, 1 H, H-5a, J
5a,5b = 11.8 Hz), 3.32 (d, 1 H, H-5b), 1.56 (s, 3 H, CH3), 1.38 (s, 3 H, CH3). 13C NMR (CD3OD): δ = 176.4 (1 C, C=O), 112.8 (1 C, CH3
CCH3), 106.1 (1 C, C-1), 81.9 (1 C, C-2), 81.8 (1 C, C-4), 68.8 (1 C, C-3), 45.6 (1 C, C-5), 26.4, 26.0 (2 C, CH3). IR (ATR): ν = 2959, 2932, 1716, 1659, 1465, 1382, 1233, 1166, 1098, 1082, 1001 cm-1. HRMS: m/z calcd for C9H14N2O4Na: 237.0851 [M + Na]+; found: 237.0850.
3,5-Diamino-3- C -carboxy-3,5-dideoxy-1,2- O -isopropyl-idene-α- d-ribofuranose ( 18). White solid, mp 200 °C; [α]D 20 77 (c 0.21, H2O). 1H NMR (D2O): δ = 5.88 (d, 1 H, H-1, J 1,2 = 3.6 Hz), 4.55 (d, 1 H, H-2), 3.94 (dd, 1 H, H-4, J 4,5a = 1.8 Hz), 3.13 (dd, 1 H, H-5a, J 5a,5b = 13.3 Hz), 2.78 (dd, 1 H, H-5b, J 5b,4 = 9.9 Hz), 1.44 (s, 3 H, CH3), 1.27 (s, 3 H, CH3). 13C NMR (D2O): δ = 175.1 (1 C, C=O), 113.4 (1 C, CH3 CCH3), 105.9 (1 C, C-1), 83.3 (1 C, C-2), 80.3 (1 C, C-4), 68.5 (1 C, C-3), 40.1 (1 C, C-5), 26.1, 25.7 (2 C, CH3). IR (ATR): ν = 2987, 2917, 1614, 1540, 1409, 1381, 1230, 1163, 1069, 1015, 883, 809 cm-1. HRMS: m/z calcd for C9H16N2O5Na: 255.0957 [M + Na]+; found: 255.0950.
16
(1
R
,3
R
,4
R
,5
R
)-5-{[1,2-
O
-Isopropylidene-α-
d-xylo-furanos-5-yl]amino}-6-amino-3,4-
O
-isopropylidene-7-aza-2-oxabicyclo[3.3.0]oct-6-ene (
21).
White solid, mp 125-128 °C; [α]D
20 18.2 (c 0.36, CHCl3). IR (ATR): 2989, 2901, 1655, 1384, 1217, 1167, 1073, 1014, 879, 858 cm-1. 1H NMR (CDCl3): δ = 5.89 (d, 1 H, H-1, J
1,2 = 3.6 Hz), 5.77 (d, 1 H, H-1′, J
1
′
,2
′ = 3.7 Hz), 4.62 (d, 1 H, H-2′), 4.52 (s, 1 H, H-4), 4.38 (d, 1 H, H-2), 4.14 (d, 1 H, H-4′, J
4
′
,3
′ = 2.7 Hz), 4.05 (d, 1 H, H-3′), 3.56 (s, 2 H, H-5′), 3.06 (d, 1 H, H-5a, J
5a,5b = 11.7 Hz), 2.77 (dd, 1 H, H-5b, J
5b,4 = 3.5 Hz), 1.48 (s, 3 H, CH3), 1.39 (s, 3 H, CH3), 1.29 (s, 3 H, CH3), 1.20 (s, 3 H, CH3). 13C NMR (CDCl3): δ = 164.9 (1 C, CN), 112.9, 111.5 (2 C, CH3
CCH3), 105.2, 104.8 (2 C, 2 C-1), 85.6 (1 C, C-2), 83.1 (1 C, C-4), 82.2 (1 C, C-2′), 77.9 (1 C, C-4′), 76.5 (2 C, C-3′, C-3), 58.2 (1 C, C-5′), 42.4 (1 C, C-5), 27.3 (1 C, CH3), 27.1 (1 C, CH3), 26.7 (1 C, CH3), 26.1 (1 C, CH3). HRMS: m/z calcd for C17H28N3O7: 386.1927 [M + H]+; found: 386.1908. Anal. Calcd for C17H27N3O7: C, 52.98; H, 7.06; N, 10.90. Found: C, 52.91; H, 7.04; N, 10.87.
3,5-Diamino-3-
C
-carboxy-3,5-dideoxy-3-
N
-[1′,2′-
O
-isopropylidene-α-
d-xylofuranos-5′-yl]-1,2-
O
-isopropyl-idene-α-
d-ribofuranose (
22).
White solid, mp 254-256 °C; [α]D
25 8.0 (c 0.21, CHCl3). IR (ATR): 2987, 2900, 1589, 1394, 1215, 1066 cm-1. 1H NMR (CD3OD): δ = 5.99 (d, 1 H, H-1′, J
1
′
,2
′ = 3.6 Hz), 5.95 (d, 1 H, H-1, J
1,2 = 3.8 Hz), 5.01 (d, 1 H, H-2), 4.49 (d, 1 H, H-2′), 4,22 (m, 2 H, H-4′, H-3′), 3.98 (t, 1 H, H-4, J
4,5 = 6.8 Hz), 3.12 (d, 2 H, H-5), 3.56 (dd, 2 H, H-5a′, J
5a,5b = 11.7 Hz, J
5a,4 = 6.3 Hz), 2.71 (dd, 1 H, H-5b′, J
5b,4 = 7.3 Hz), 1.56 (s, 3 H, CH3), 1.47 (s, 3 H, CH3), 1.38 (s, 3 H, CH3), 1.31 (s, 3 H, CH3). 13C NMR (CD3OD): δ = 174.6 (1 C, C=O), 112.3, 111.6 (2 C, CH3
CCH3), 106.8, 105.4 (2 C, C-1′, C-1), 85.2 (1 C, C-2′), 81.2 (1 C, C-2), 80.8 (1 C, C-4′), 77.8 (1 C, C-4), 76.5 (2 C, C-3′, C-3), 43.1 (1 C, C-5′), 40.9 (1 C, C-5), 26.4 (1 C, CH3), 26.2 (1 C, CH3), 25.7 (1 C, CH3), 25.5 (1 C, CH3). HRMS: m/z calcd for C17H28N2O9Na: 427.1693
[M + Na]+; found: 427.1685.